Integrated COPD study sees hospitals and GPs working together

Hundreds of patients with chronic obstructive pulmonary disease (COPD) have been recruited to a pioneering study featuring collaboration between primary and secondary care. Led by Heartlands Hospital, part of BHP founder member University Hospitals Birmingham NHS Foundation Trust (UHB), the study has rolled out across all GP practices in Birmingham. Over 700 patients have already … Continue reading “Integrated COPD study sees hospitals and GPs working together”

New partner announced as part of lung cancer research

Mirati Therapeutics, Inc. has been announced as the latest partner of Cancer Research UK’s Stratified Medicine Programme which is being carried out in collaboration with the University of Birmingham Cancer Research Clinical Trials Unit. The partnership will make Mirati’s experimental drug, sitravatinib, available for inclusion in the programme through the National Lung Matrix Trial – … Continue reading “New partner announced as part of lung cancer research”

BHP founder member becomes part of the National NIHR BioResource network

The Centre for Rare Diseases at the Queen Elizabeth Hospital Birmingham, part of the BHP campus, has this week become part of the NIHR (National Institute for Health Research) BioResource network. The BioResource team at will be led by Dr Graham Lipkin while Humeira Hafsa, research nurse, will take on the role of Clinical Trials … Continue reading “BHP founder member becomes part of the National NIHR BioResource network”

World’s first specialist research centre aims to eliminate scarring within a generation

The first military and civilian wound research centre of its kind in the world was officially opened at the Queen Elizabeth Hospital in Birmingham today, aiming to minimise the psychological and physical impact of scarring among armed forces personnel and civilians wounded in terrorist attacks. The Scar Free Foundation Centre for Conflict Wound Research is … Continue reading “World’s first specialist research centre aims to eliminate scarring within a generation”

Personalised medicine to treat leukaemia is now one step closer

Scientists at the University of Birmingham, a BHP founding member, have revealed the roles that different types of gene mutations play in causing blood cancers in a study that was the culmination of a decade’s research. The findings of the team, led by Professor Constanze Bonifer and Professor Peter Cockerill of the University’s Institute of … Continue reading “Personalised medicine to treat leukaemia is now one step closer”